Ashley Moffett and Peter Thelin made honorary doctors at Karolinska Institutet
Karolinska Institutet has decided to award honorary doctorates to Ashley Moffett, professor emerita at the University of Cambridge, UK, and Peter Thelin, chair of the Swedish Brain Fund, for their important contributions to science and KI, respectively. The formal ceremony will take place at the conferment ceremony in Stockholm City Hall on 26 April.
Professor Ashley Moffet is awarded KI’s honorary doctorate for a lifetime of research that has made groundbreaking discoveries concerning the biological mechanisms behind serious conditions associated with pregnancy. These include preeclampsia, intrauterine growth restriction (IUGR) and unexplained fetal death, which together affect up 10 per cent of all pregnancies.
Focus on diseases during pregnancy
Professor Moffet’s research has found that these diseases originate from critical interactions between natural killer (NK) cells in the decidua (the part of the uterus where the embryo is implanted) and the cells that form the placenta (trophoblasts), which derive from the fetus.
“I am deeply honoured to receive the honorary doctorate from Karolinska Institutet,” says Ashley Moffett, who is a doctor and specialist in obstetrics and gynaecology. “Karolinska Institutet was where NK cells were first discovered and described. These groundbreaking studies have been absolutely essential to my work as a researcher.”
Internationally, Professor Moffett has been recognised for her work in developing countries, such as Uganda, where she has helped to develop national programmes for research, education and information in the field of maternal healthcare.
Key research financier
Peter Thelin, the chair of the Swedish Brain Fund and co-founder of the financial company Brummer & Partners, has spent over a decade putting a great deal of his time and energy into research at Karolinska Institutet – a commitment that has resulted in long-term funding for many research groups at KI.
“I’m proud and delighted to receive this recognition,” he says. “I’ve had the privilege to work for KI for over 15 years and have been a private donor. As chair of the Brain Fund, I get regular confirmation of just how important KI’s research is. I shall do the title due justice.”
Thelin was an active participant in the anniversary campaign committee ahead of KI’s bicentenary celebrations in 2010. The committee raised SEK 1 bullion and KI forged new links with donors from many sections of society.
As a member of KI’s investment council, which decides on KI’s foundations and donations, Thelin has given prudent advice and played an important part in securing higher yields on KI’s investments.
Thelin is also a member of KI’s philanthropic council, and has served as an advisor in raising research funds for several KI presidents.
Increased funding for research on brain diseases
Grants from the Swedish Brain Fund support brain research in Sweden and KI. Since Peter Thelin became the chair of the Swedish Brain Fund in 2016, the raising and distribution of funds has increased markedly.
This has given rise to a greater understanding of complex brain processes and thus new therapeutic strategies for such diseases as stroke, Parkinson’s, ALS and Alzheimer’s.
Honorary doctorates at Karolinska Institutet
Karolinska Institutet (KI) confers honorary doctorates upon academics who have made vital scientific achievements or significant contributions to KI, or to individuals who have not achieved a doctoral degree formally but who have otherwise been instrumental in the advancement of research and development. Since the first appointments in 1910, 325 honorary doctorates have been awarded at Karolinska Institutet.
Contacts
Contact the Press Office and download photo: ki.se/pressroom
Images
Karolinska Institutet (http://ki.se/en) is one of the world’s leading medical universities. Our vision is to advance knowledge about life and strive towards better health for all. Karolinska Institutet accounts for the single largest share of all academic medical research conducted in Sweden and offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.
Subscribe to releases from Karolinska Institutet - English
Subscribe to all the latest releases from Karolinska Institutet - English by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Karolinska Institutet - English
Very early medication abortion is effective and safe6.11.2024 23:00:00 CET | Pressmeddelande
Clinics and hospitals currently defer medication abortion until ultrasound confirms a pregnancy inside the uterus. However, a large international study led by researchers from Karolinska Institutet now indicates that treatment can be equally effective and safe even before the sixth week of pregnancy. The study is published in The New England Journal of Medicine.
The 2024 Nobel Prize in Physiology or Medicine jointly to Victor Ambros and Gary Ruvkun7.10.2024 12:15:58 CEST | Press Release
The Nobel Assembly at Karolinska Institutet has today decided to award the 2024 Nobel Prize in Physiology or Medicine jointly to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
Announcement of the Nobel Prize in Physiology or Medicine 202426.9.2024 17:00:00 CEST | Pressinbjudan
The Nobel Prize will be announced on Monday 7 October 2024 at 11.30 am (at the earliest).The announcement will be open only for media representatives who have been accredited in advance.
Breaking the trend: Skin cancer incidence in young adults declines9.9.2024 00:05:00 CEST | Pressmeddelande
The risk of skin cancer for adults under the age of 50 is now decreasing for the first time in Sweden, according to a study from Karolinska Institutet published in JAMA Dermatology.
New research explains differences between men's and women's immune systems4.9.2024 17:00:00 CEST | Pressmeddelande
In a recent study published in Nature, Swedish researchers demonstrate the role of sex hormones in regulating the immune system. This newfound knowledge explains differences between men and women and can be used to develop new immunological medications according to researchers.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom